financetom
Business
financetom
/
Business
/
BRIEF-Iron Horse Acquisition Corp II Files For IPO Of Up To $250 Million - SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
BRIEF-Iron Horse Acquisition Corp II Files For IPO Of Up To $250 Million - SEC Filing
Jan 17, 2025 12:20 PM

Jan 17 (Reuters) - Iron Horse Acquisition Corp II:

* BLANK CHECK CO, IRON HORSE ACQUISITION CORP II FILES FOR

IPO OF

UP TO $250 MILLION - SEC FILING

* IRON HORSE ACQUISITION CORP II SAYS APPLIED TO HAVE UNITS

LISTED

ON NASDAQ

* IRON HORSE ACQUISITION CORP II - PROPOSED IPO PRICE IS AN

ESTIMATE SOLELY FOR CALCULATING SEC REGISTRATION FEE

* IRON HORSE ACQUISITION CORP II SAYS D. BORAL CAPITAL IS

UNDERWRITER TO IPO

Source text:

;))

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Why Target Hospitality Shares Are Shooting Higher Today
Why Target Hospitality Shares Are Shooting Higher Today
Mar 25, 2024
Shares of Target Hospitality Corp ( TH ) are trading higher after the workforce lodging company’s Board of Directors received an unsolicited non-binding proposal from Arrow Holdings S.à r.l. Arrow, an affiliate of TDR Capital LLP, has offered to acquire all of the outstanding shares of common stock of Target Hospitality ( TH ) that they do not own for cash consideration of $10.80...
Update: AbbVie to Acquire Landos Biopharma For About $137.5 Million; Landos Shares Jump
Update: AbbVie to Acquire Landos Biopharma For About $137.5 Million; Landos Shares Jump
Mar 25, 2024
10:21 AM EDT, 03/25/2024 (MT Newswires) -- (Updates to include recent stock movement in the headline and first paragraph.) Landos Biopharma ( LABP ) shares surged about 170% in recent Monday trading after the company and AbbVie ( ABBV ) said they signed an agreement under which AbbVie ( ABBV ) will acquire the latter for $20.42 per share in...
Cassava Sciences Announces Completion of Interim Safety Review for Alzheimer's Drug Candidate Simufilam
Cassava Sciences Announces Completion of Interim Safety Review for Alzheimer's Drug Candidate Simufilam
Mar 25, 2024
10:19 AM EDT, 03/25/2024 (MT Newswires) -- Cassava Sciences ( SAVA ) on Monday announced the completion of another interim safety review of its drug candidate simufilam in ongoing Phase 3 clinical trials involving Alzheimer's disease patients. An independent data and safety monitoring board recommended continuing the phase 3 clinical trials of simufilam in patients with Alzheimer's disease as planned....
RBC Capital Markets Comments On CGI's Job Postings In Fiscal Q1
RBC Capital Markets Comments On CGI's Job Postings In Fiscal Q1
Mar 25, 2024
10:20 AM EDT, 03/25/2024 (MT Newswires) -- RBC Capital Markets said Monday that CGI Inc. (GIB-A.TO)'s job postings were sequentially stable in the fiscal quarter of its fiscal 2024, which is well below peak levels, but down 36% year over year. RBC said the predictive model from its in-house data science team suggests that CGI's organic growth in the fiscal...
Copyright 2023-2026 - www.financetom.com All Rights Reserved